Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the company is scheduling an H2 FY2026 Investor Conference Call on Wednesday, 10th June 2026, to discuss the Audited Financial Results of the Company for the half year and year ended 31st March 2026. The meeting may be cancelled, rescheduled or postponed due to exigencies on the part of Analysts, investors and/or Company officials. The company has enclosed a copy of the Invitation with access Link to dial-in details.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1806.45 |
| Dr. Reddys Lab | 1279.25 |
| Cipla | 1381.50 |
| Zydus Lifesciences | 1087.75 |
| Lupin | 2273.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: